This text is a result of machine translation.
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Shenzhen textile A: the order of line 7 is full, and the production line speed is climbing
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Half day main capital net inflow of power equipment, non bank finance, selling banks, etc
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Updated 3 hours ago
Successful Multinational Corporations in China Series: Qualcomm China
Jun 25, 2022 02:02 PM